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Abstract Extraocular muscles (EOM) are typically
spared in Duchenne muscular dystrophy. We hypothe-
sized that this might be due to diﬀerent patterns of
utrophin expression. The expression of utrophin was
examined in EOM of normal cats using immunohisto-
chemical methods and Western blot. For detecting ace-
tylcholine receptors (AChR), we used a-bungarotoxin.
Surprisingly, a-bungarotoxin failed to stain the AChR
and no expression of utrophin could be detected at the
neuromuscular junctions. Our study could indicate that
the expression of utrophin is dependent on the structure
of the AChR.
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Introduction
Duchenne muscular dystrophy (DMD) is one of the
most common inherited neuromuscular diseases and
occurs in about 1:3,500 live male births (Worton 1995).
DMD is characterized by the almost complete absence
of dystrophin either due to promoter defects or nonsense
mutations and deletions leading to an unstable tran-
script or protein. In DMD, extraocular muscles (EOM)
remain unaﬀected during the course of the disease
(Kaminski et al. 1992; Karpati et al. 1988; Khurana
et al. 1995; Ragusa et al. 1996). The compensatory fac-
tors or mechanisms that allow EOM to escape the
consequence of dystrophin deﬁciency are unknown. One
hypothesis is that an alternative expression of a protein
that is structurally and functionally homologous to the
defective dystrophin could save EOM by assuming the
role of dystrophin. This would prevent the loss of other
vital components of the transmembrane protein com-
plex, thereby stabilizing the sarcolemma and providing
myoﬁber survival. A possible candidate for such a
function is utrophin, which has a ubiquitous expression
pattern in the brain (Khurana et al. 1990), muscle
(Nguyen et al. 1991) and other tissues (Love et al. 1991).
In normal mature striated muscle, utrophin expression is
detected at the neuromuscular (Nguyen et al. 1991;
Takemitsu et al. 1993) and myotendinous junctions
(Khurana et al. 1992), in the wall of endomysial capil-
laries and other blood vessels and in the perineurium
and Schwann cells of the intramuscular nerves (Karpati
et al. 1993). During ontogeny (Lin and Burgunder 2000)
and regeneration (Lin et al. 1998), it is found at the
whole sarcolemma. The utrophin and dystrophin genes
exhibit a marked degree of homology although the
utrophin gene is smaller (Brown 1997). Both dystrophin
and utrophin proteins have the same four domains: the
amino terminus, the rod domain, the cysteine-rich
domain and the carboxy terminus. Both proteins have
almost the same molecular weight (dystrophin 427 kDa,
utrophin 420 kDa) and the same associated proteins
(dystroglycans, sarcoglycans, and syntrophins).
There are three animal models of DMD: mdx mouse
(Bulﬁeld et al. 1984; Cooper 1989; Hoﬀmann 2001), dog
(Cooper et al.1988a, b; Kornegay et al. 1988) and cat
(Carpenter et al. 1989; Gaschen et al. 1992; Winand et al.
1994). They all lack dystrophin in skeletal muscle tissue
because of loss-of-function mutations in the highly
M. Assadi (&) Æ M. Mu¨ntener
Institute of Anatomy, University of Zu¨rich-Irchel,
Zu¨rich, Switzerland
M. Mu¨ntener
Department of Chemistry and applied Biosciences,
ETH, Zu¨rich, Switzerland
M. Assadi
F. Hoﬀmann-La Roche, 93/8.08, 4070 Basel, Switzerland
E-mail: maziar.assadi@roche.com
Histochem Cell Biol (2005) 123: 189–194
DOI 10.1007/s00418-005-0762-9
conserved dystrophin gene. The clinical phenotype of
each animal model diﬀers from the human disease and
from one another. The fact that they show diﬀerences in
phenotype is valuable in that they provide insight into the
secondary consequences of primary dystrophinopathy.
Our hypothesis for the sparing of EOM in DMD was
that in normal EOM, utrophin is naturally overexpres-
sed at the extrajunctional sites and replaces dystrophin.
Because cat is one of the animal models of DMD, we
studied the expression of utrophin in EOM and leg
muscles of normal cats using immunohistochemical
methods and Western blot.
Materials and methods
Tissue
Three domestic cats and one Wistar rat without appar-
ent myopathy were obtained from the department for
veterinary medicine of the University of Zu¨rich. The cats
and the rat were killed with a high dose of anesthetics in
accordance with the guidelines of the local animal care
committee. Samples of EOM and leg muscles (quadri-
ceps muscle) were taken immediately after death and
were snap-frozen in isopentane cooled in liquid nitrogen.
Until the analysis, the biopsies were stored at 70C.
Histology
Detection of utrophin and acetylcholine receptors
(AChR)
Peroxidase immunohistochemistry For the histological
procedures, the muscle specimens were sectioned in a
cryostat at 7 lm and dried overnight at room tempera-
ture. Processing of sections for detecting utrophin with
peroxidase immunohistochemistry was performed as
described by Lin et al. (1998). A monoclonal antibody
against the amino terminus of utrophin was used (NCL-
DRP2, Novocastra Laboratories Ltd.). The second
antibody was a biotinylated sheep antimouse antibody
(RPN1001, Amersham Biosciences) followed by perox-
idase-conjugated streptavidin (016-030-084, Jackson
ImmunoResearch Laboratories Inc.). Peroxidase activ-
ity was visualized using DAB tablets (DO426, Sigma).
Fig. 1 Neuromuscular junctions (NMJ) were stained in leg muscles
(a–d) and extraocular muscles (EOM) (e–h) of cat. Double staining
with a-bungarotoxin/utrophin showed a positive staining for both
utrophin (a) and a-bungarotoxin in leg muscles (b). In EOM,
neither utrophin (e) nor a-bungarotoxin (f) could be detected. By
using the method of Karnovsky on consecutive sections, NMJ
could be shown in leg muscles (c) and EOM (g). NMJ could also be
detected with rapsyn in leg muscles (d) and EOM (h)
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Fluorescence immunohistochemistry The same protocol
as for peroxidase immunohistochemistry was adapted
for ﬂuorescence immunohistochemistry. Sections were
double-stained either with utrophin/a-bungarotoxin or
with rapsyn/a-bungarotoxin. a-bungarotoxin binds to
the extracellular part of the AChR whereas rapsyn
interacts with the cytoplasmatic part of the AChR.
a-bungarotoxin was conjugated with Alexa Fluor 488
(B-13422, Molecular Probes). Primary antibodies were:
(1) monoclonal antibody against the amino terminus of
utrophin (NCL-DRP2, Novocastra Laboratories) and
(2) rabbit polyclonal antibody against rapsyn (see
Acknowledgments). Utrophin was detected with donkey
antimouse antibody conjugated with Texas Red
(715-075-150, Jackson ImmunoResearch Laboratories).
For detection of rapsyn, sections were incubated with a
biotinylated goat antirabbit antibody (B-2770, Molecu-
lar Probes) followed by Texas Red conjugated strepta-
vidin (RPN1233V, Amersham Biosciences).
Staining of acetylcholinesterase (AChE)
Neuromuscular junctions (NMJ) were demonstrated by
staining for AChE activity using the method of Kar-
novsky (Karnovsky and Roots 1964). All the prepara-
tions were examined with a Polyvar 2 microscope
(Reichert-Jung) equipped with a CCD camera (Visitron
Systems). The digital pictures were processed with
Adobe Photoshop 7.
Western blot
For the Western blot, we used a protocol established by
Anderson and Davison (1999). As primary antibody, a
monoclonal antibody against the amino terminus of
utrophin (NCL-DRP2, Novocastra Laboratories) was
used. Goat antimouse IgG conjugated with peroxidase
(A-2554, Sigma) was detected with ECL Western blot-
ting detection reagents (RPN2109, Amersham Bio-
sciences).
Results
Muscle tissue
In leg muscles, the utrophin distribution (Fig. 1a) was
restricted to NMJ as shown by double staining with
a-bungarotoxin (Fig. 1b). In EOM, there was neither
any utrophin immunoreactivity (Fig. 1e) nor a positive
staining of the AChR with a-bungarotoxin (Fig. 1f)
along the sarcolemma of any muscle ﬁber.
On consecutive sections, we also used the method of
Karnovsky for detecting NMJ. In leg muscles, the
staining of AChE (Fig. 1c) showed the same pattern as
staining with a-bungarotoxin. AChE staining of the
EOM showed an occurrence of NMJ (Fig. 1g), in con-
trast to the staining with a-bungarotoxin. For checking
our results about the distribution of NMJ, we did a
double staining with a-bungarotoxin and a polyclonal
Fig. 2 Utrophin was detected
with Western blot in leg muscles
and extraocular muscles
(EOM) (a). The double bands
on both blots were interpreted
as degradation products (*).
Staining with indirect
peroxidase immunohisto-
chemistry in EOM showed a
positive signal for utrophin in
blood vessels (b) and nerves (c)
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antibody against rapsyn. Slides from leg muscles
(Fig. 1d) and the EOM (Fig. 1h) showed a positive
staining of the AChR with rapsyn. The staining of the
AChR with a-bungarotoxin showed again a positive
result only in leg muscle but not in the EOM (data not
shown). The Western blot analysis of both leg muscles
and EOM showed a low level of expression for utrophin
(Fig. 2a). The double band on both blots could be due to
degradation products.
Nerves and blood vessels
Staining of utrophin with indirect peroxidase reaction
showed in EOM a positive result in blood vessels
(Fig. 2b) and nerves (Fig. 2c). The same was found in
leg muscles (data not shown).
Discussion
Speciﬁc skeletal muscles are involved in a selective
manner during muscular dystrophy. It is well known that
in mdx mouse the small-caliber skeletal muscle ﬁbers are
less aﬀected although dystrophin is deﬁcient in all muscle
ﬁbers (Karpati et al. 1988). In DMD patients, EOM are
structurally and functionally spared during the whole
course of the disease. In hematoxylin and eosin staining,
EOM lack the cardinal pathological manifestation of
dystrophin deﬁciency such as hypertrophy, ﬁber size
variation, ﬁber splitting, central nucleation, fatty
degeneration and ﬁbrotic scarring (Khurana et al. 1995).
Also, clinical study of the ocular motility of DMD pa-
tients using infrared oculography showed the absence of
altered function (Kaminski et al. 1992). The sparing of
EOM in DMD may be linked to diﬀerences in mor-
phology, cell and molecular biology of this muscle group
compared with other skeletal muscles (Porter et al. 1997).
In this study, we evaluated the hypothesis that
utrophin would also be expressed outside NMJ in
normal EOM and thus could replace dystrophin in
DMD. We used immunohistochemical methods to
investigate distribution of utrophin along the sarco-
lemmal membrane in normal EOM and leg muscles of
cats. For comparing the expression level of utrophin in
these two muscles, we used Western blot. Our results
clearly showed that in cat, there is a diﬀerent expres-
sion of utrophin in EOM compared with other skeletal
muscles. In leg muscles, the distribution of utrophin
was restricted to NMJ while in EOM, we could not
detect any immunoreactivity of utrophin. Another
interesting ﬁnding was that by using a-bungarotoxin,
we could detect NMJ in leg muscles but not in EOM
while staining of AChE showed NMJ in both muscles.
For checking these results, a double staining of AChR
with a-bungarotoxin and an antibody against rapsyn
was performed. In leg muscles, AChR were detected
with both a-bungarotoxin and rapsyn. In EOM, there
was again no signal for a-bungarotoxin although NMJ
could be shown with rapsyn.
Our study shows two surprising ﬁndings in EOM of
normal cat: the lack of utrophin at NMJ and the failure
of staining AChR with a-bungarotoxin. To our knowl-
edge, there is no study about the distribution of utrophin
in EOM of cat. Further, we also could not ﬁnd any data
about staining with a-bungarotoxin NMJ in EOM of
cat.
We are aware that our results contradict reports from
other groups. In diﬀerent studies, the expression of
utrophin in EOM was examined (Khurana et al. 1995;
Porter et al. 1998). In addition, various papers showed
a-bungarotoxin staining in EOM of a variety of species
(Briggs and Schachat 2002; Khanna et al. 2003; Kusner
et al. 1999; Lukas et al. 2000). None of these treatises
were done in EOM of cat. Nevertheless, there are dif-
ferent reasons which could let assume that our negative
results are not true and were caused by processing ar-
tefacts:
1. The NMJ was missing in the serial sections chosen for
the double staining of utrophin and a-bungarotoxin.
To exclude this possibility, diﬀerent samples from all
three cats were cut along the tendon-to-tendon length
of the muscle. The results presented in Fig. 1e–g are
representative of our ﬁndings in all these sections.
2. Our protocol for the staining of NMJ with a-bun-
garotoxin was not suitable for EOM. To ﬁnd out if
this could be true, we applied the same protocol in
EOM of a rat. Like in previous reports, we were able
to detect NMJ with a-bungarotoxin in this species.
On account of all the controls performed, we believe that
it is rather unlikely that our results were caused by a
technical failure.
In normal mature striated muscle, utrophin expres-
sion is also detected in the wall of blood vessels and in
the perineurium and Schwann cells of intramuscular
nerves (Karpati et al. 1993). In EOM of cat, we did not
ﬁnd utrophin at the NMJ, but we were able to detect
utrophin in blood vessels and nerves of this muscle
group. This result explains why the Western blot of
EOM showed a low expression level for utrophin al-
though in the immunohistochemical analysis of this
muscle group, no utrophin was found at NMJ.
The AChR are a large complex of four transmem-
brane glycoprotein subunits, which form an a2bcd pen-
tameric complex (Raftery et al. 1980). a-bungarotoxin
binds to AChR by interacting with the extracellular part
of a-subunits (Harel et al. 2001; Moise et al. 2002;
Young et al. 2003). Rapsyn interacts with the cytoplas-
matic part of all subunits of AChR (Huebsch and
Maimone 2003; Maimone and Merlie 1993; Willmann
and Fuhrer 2002). Therefore, one possible explanation
as to why in EOM of cats NMJ are detectable with
rapsyn but not with a-bungarotoxin could be that in this
species, a-subunits of AChR do not have the binding site
for a-bungarotoxin.
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At NMJ, utrophin is found at the crests of junctional
folds whereas dystrophin occurs mainly in troughs (Be-
wick et al. 1992). AChRare also concentrated at the crests
(Flucher and Daniels 1989). The clear functional role of
utrophin and its interaction with AChR remain unclear.
There are diﬀerent explanations as to why we could
not detect utrophin expression at NMJ in EOM of cat.
One could be that in this species, utrophin is expressed at
NMJ of EOM without the epitope that is recognized by
the antibody we used in our study. Another interpretation
of the outcome of our study would be that utrophin
does not occur at NMJ of EOM because its expression
depends on the structure of a-subunits of AChR.
We believe that the lack of utrophin at NMJ in EOM
of cat is not an artefact but a true result. A possible
explanation could be that in EOM of cat, NMJ are ar-
ranged diﬀerently from other species. Further studies are
needed for a better characterization of AChR and their
subunits in EOM of cat. Also, a more speciﬁc method
than Western blot has to be used to better distinguish
between expression of utrophin in muscle ﬁbers of EOM
and their blood vessels and nerves.
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